Endo step Up Flashcards
when is insuline released
response to glucose intake
secreted by pancreatic beta islet cell
effects of insulin
induce glucose and aa uptake by muscle, adipose and liver
glucose to glycogen fatty acids and pyruvate
inhibits lipolysis
where and when is glucagon released
by alpha islet cells in response to decreased glucose and protein intake
promotes breakdown of glycogen and fatty acids
What HLA is assoc with DM I
HLA DR3 DR4 and DQ
signs of DM I
polyuria polydipsia, polyphagia, weight loss
rapid onset
labs of DMI I
hyperglycemia, glycosuria, serum and urine ketones, increase HbA1c
what happens if DM I patient gives too much insulin
hypoglycemia
what illnesses are associated with onset beta cell destruction
rubella
coxsackie virus and mumps
risk factors DM II
FMH obesity metabolic syndrome, lack of exercise, gestational DM
Dx criteria DM
random plasma glucose >200 with Sx
fasting glucose >126 on 2 separate occasions
plasma glucose >200 2 hrs after 75 g oral glucose load
HbA1c>6.5%
what are the rapid acting insulin
lispro, asoart and glulisine
what are the long acting insulins
NPH, glargine and detemir
diabetic ketoacidosis is complication of what
DM I only
complication dM II
hyperosmolar hyperglycemic nonketotic syndrome retinopathy nephropathy neuropathy atherosclerosis
what leads to DKA
low insulin
glucagon excess leading to dehydration of TG that eventually turn to ketoacids
so not taking insuline or have infection,stress, MI or high alcohol use
signs DKA
weakness, polyuria, polydipsia, abdominal pain, vomiting, dry mucous membranes, decreased skin turgor, fruity odor on breath, hyperventilation, kussmaul breathing, mental status changes from dehydration
how does metformin work
decrease hepatic gluconeogenesis
increase insulin sensitivity
side effects metformin
GI
dec B12 absorption
CI in those with hepatic or renal insufficiency
what are the sulfonylurea drug names
glyburide glimepriride, glipizide
how do sulfonlyureas work
stimulate insulin release from beta cells, reduce serum glucagon, increase binding insulin to tissue R
adverse effects of sulfonylureas
hypoglycemia. CI in those with hepatic or renal insufficiency
Mechanism of thiazolidinediones
decrease gluconeogenesis
increase insulin sensitivity
thiazolidinediones are CI in what patients
CHF
what are the gliptins
DDP-IV inhibitors that inhibit degradation of incretin. cause decreased glucagon and increased insulin
delay gastric emptying so can cause diarrhea or constipation